Pfizer (PFE) PT Lowered to $40 at Morgan Stanley
Tweet
Share
E-mailGet Alerts PFE Hot Sheet
Price: $26.79 -0.04%
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
14 Buy, 20 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Morgan Stanley analyst Terence Flynn lowered the price target on Pfizer (NYSE: PFE) to $40.00 (from $42.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- EMA validates Pfizer and Valneva's Lyme disease vaccine application
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
